Weight-loss devices maker EnteroMedics says it’s still on track with its premarket approval application, expecting a decision early next year despite the FDA’s request for more information. Minnesota medical device maker EnteroMedics (NSDQ:ETRM) appeared unfazed by the FDA’s response to the company’s premarket approval application, anticipating no slowdown in the regulatory process for its landmark Maestro weight-loss implant.
Help employers find you! Check out all the jobs and post your resume.
